Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987804 | SCV001137260 | uncertain significance | Autosomal recessive ataxia, Beauce type | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001265864 | SCV001444036 | uncertain significance | Inborn genetic diseases | 2019-05-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001288048 | SCV001474864 | uncertain significance | not provided | 2020-07-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001858678 | SCV002285086 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2023-12-21 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 3234 of the SYNE1 protein (p.Glu3234Lys). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 802283). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001288048 | SCV002765242 | uncertain significance | not provided | 2022-12-14 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32686686) |